Parsian Pharmaceutical Company has consistently advanced and diversified its product portfolio by leveraging the expertise and capabilities of its specialists. Currently, with 50 molecules in development and venturing into the production of high-tech peptide drugs, Parsian Pharmaceuticals is continuously expanding its portfolio.